291 related articles for article (PubMed ID: 26652455)
1. Preparation and characterization of glycidyl methacrylate organo bridges grafted mesoporous silica SBA-15 as ibuprofen and mesalamine carrier for controlled release.
Rehman F; Rahim A; Airoldi C; Volpe PLO
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():970-979. PubMed ID: 26652455
[TBL] [Abstract][Full Text] [Related]
2. The applicability of ordered mesoporous SBA-15 and its hydrophobic glutaraldehyde-bridge derivative to improve ibuprofen-loading in releasing system.
Rehman F; Volpe PL; Airoldi C
Colloids Surf B Biointerfaces; 2014 Jul; 119():82-9. PubMed ID: 24819430
[TBL] [Abstract][Full Text] [Related]
3. Amine bridges grafted mesoporous silica, as a prolonged/controlled drug release system for the enhanced therapeutic effect of short life drugs.
Rehman F; Ahmed K; Airoldi C; Gaisford S; Buanz A; Rahim A; Muhammad N; Volpe PLO
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():34-41. PubMed ID: 28024595
[TBL] [Abstract][Full Text] [Related]
4. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
5. Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials.
Jadach B; Feliczak-Guzik A; Nowak I; Milanowski B; Piotrowska-Kempisty H; Murias M; Lulek J
J Biomater Appl; 2019 Apr; 33(9):1214-1231. PubMed ID: 30791849
[TBL] [Abstract][Full Text] [Related]
6. "Graft to" Synthesis and Ibuprofen-Loading Performance of pH-Sensitive PMAA-Silica Hybrid Nanoparticles with Controlled Bimodal Mesopores.
Han J; Sun J; Bai S; Panezai H; Jin X; Wu X
J Pharm Sci; 2015 Dec; 104(12):4299-4306. PubMed ID: 26501935
[TBL] [Abstract][Full Text] [Related]
7. Studies on a new carrier of trimethylsilyl-modified mesoporous material for controlled drug delivery.
Tang Q; Xu Y; Wu D; Sun Y; Wang J; Xu J; Deng F
J Control Release; 2006 Aug; 114(1):41-6. PubMed ID: 16784793
[TBL] [Abstract][Full Text] [Related]
8. Submicron particles of SBA-15 modified with MgO as carriers for controlled drug delivery.
Shen S; Chow PS; Chen F; Tan RB
Chem Pharm Bull (Tokyo); 2007 Jul; 55(7):985-91. PubMed ID: 17603186
[TBL] [Abstract][Full Text] [Related]
9. Controlled drug delivery system based on ordered mesoporous silica matrices of captopril as angiotensin-converting enzyme inhibitor drug.
Popovici RF; Seftel EM; Mihai GD; Popovici E; Voicu VA
J Pharm Sci; 2011 Feb; 100(2):704-14. PubMed ID: 20740675
[TBL] [Abstract][Full Text] [Related]
10. Variation of the crystal growth of mesoporous silica nanoparticles and the evaluation to ibuprofen loading and release.
Kamarudin NH; Jalil AA; Triwahyono S; Artika V; Salleh NF; Karim AH; Jaafar NF; Sazegar MR; Mukti RR; Hameed BH; Johari A
J Colloid Interface Sci; 2014 May; 421():6-13. PubMed ID: 24594025
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity study and influence of SBA-15 surface polarity and pH on adsorption and release properties of anticancer agent pemetrexed.
Almáši M; Beňová E; Zeleňák V; Madaj B; Huntošová V; Brus J; Urbanová M; Bednarčík J; Hornebecq V
Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110552. PubMed ID: 32228921
[TBL] [Abstract][Full Text] [Related]
12. Impact of pore characteristics of silica materials on loading capacity and release behavior of ibuprofen.
Numpilai T; Muenmee S; Witoon T
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():43-52. PubMed ID: 26652347
[TBL] [Abstract][Full Text] [Related]
13. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property.
Charnay C; Bégu S; Tourné-Péteilh C; Nicole L; Lerner DA; Devoisselle JM
Eur J Pharm Biopharm; 2004 May; 57(3):533-40. PubMed ID: 15093603
[TBL] [Abstract][Full Text] [Related]
14. Ordered mesoporous silica modified with lanthanum for ibuprofen loading and release behaviour.
Goscianska J; Olejnik A; Nowak I; Marciniak M; Pietrzak R
Eur J Pharm Biopharm; 2015 Aug; 94():550-8. PubMed ID: 26170160
[TBL] [Abstract][Full Text] [Related]
15. Design and preparation of mesoporous silica carriers with chiral structures for drug release differentiation.
Wang Y; Li W; Liu T; Xu L; Guo Y; Ke J; Li S; Li H
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109737. PubMed ID: 31349514
[TBL] [Abstract][Full Text] [Related]
16. Fluorescent mesoporous silica nanotubes incorporating CdS quantum dots for controlled release of ibuprofen.
Yang YJ; Tao X; Hou Q; Chen JF
Acta Biomater; 2009 Nov; 5(9):3488-96. PubMed ID: 19442764
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and surface modification of mesoporous silica nanoparticles and its application as carriers for sustained drug delivery.
Ahmadi E; Dehghannejad N; Hashemikia S; Ghasemnejad M; Tabebordbar H
Drug Deliv; 2014 May; 21(3):164-72. PubMed ID: 24116869
[TBL] [Abstract][Full Text] [Related]
18. Diamine Functionalized Cubic Mesoporous Silica for Ibuprofen Controlled Delivery.
Sivaguru J; Selvaraj M; Ravi S; Park H; Song CW; Chun HH; Ha CS
J Nanosci Nanotechnol; 2015 Jul; 15(7):4784-91. PubMed ID: 26373038
[TBL] [Abstract][Full Text] [Related]
19. Nanoassemblies constructed from bimodal mesoporous silica nanoparticles and surface-coated multilayer pH-responsive polymer for controlled delivery of ibuprofen.
Guo Y; Sun J; Bai S; Jin X
J Biomater Appl; 2016 Sep; 31(3):411-20. PubMed ID: 27278781
[TBL] [Abstract][Full Text] [Related]
20. Preparation and physical characterization of calcium sulfate cement/silica-based mesoporous material composites for controlled release of BMP-2.
Tan H; Yang S; Dai P; Li W; Yue B
Int J Nanomedicine; 2015; 10():4341-50. PubMed ID: 26185438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
